Apollo Hospitals Enterprise Ltd
Apollo Hospitals Enterprise Q4 FY25 earnings call: Revenue & Margins
Q4 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
Apollo Hospitals expects continued healthy volume growth driven by increased patient footfall across specialties. The transcript indicates the following future growth expectations for Apollo Hospitals: - Revenue Growth: Expecting continued strong revenue growth driven by expansion in specialty and multi-specialty hospitals, and increased patient volumes.
From Apollo Hospitals Enterprise Ltd's Q4 FY25 earnings-call transcript · updated 26 Aug 2026.
Revenue & Sales Performance
- Apollo Hospitals expects continued healthy volume growth driven by increased patient footfall across specialties.
- Revenue growth is anticipated to be robust, supported by higher patient admissions and expansion of specialty services.
- The management highlighted ongoing investments in digital initiatives and expansion of hospital network to drive future growth.
- There's a focus on improving operational efficiencies to support margin improvement alongside volume growth.
2 more points from Apollo Hospitals Enterprise Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Apollo Hospitals Enterprise Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Apollo Hospitals Enterprise Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Apollo Hospitals Enterprise Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹6.6K Cr, net profit ₹551 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Apollo Hospitals's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q3 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
Others in Healthcare Services this season
- 3B Blackbio (Q4 FY25)
UK subsidiary (TRUPCR Europe Limited) revenue FY 2024-25: GBP 1,287,580, a 94% increase over FY 2023-24 GBP 664,059. Key concall takeaways from 3B Blackbio DX…
- Shalby (Q4 FY25)
Implant business is in high-growth mode: 4x growth in Indonesia, 35-40% growth in U.S., and 2.5x growth in India reported last year. Key concall takeaways from…
- Suraksha Diagno. (Q4 FY25)
Volume of tests conducted has been growing at around 10% year-on-year between FY '24 and FY '25. Key concall takeaways from Suraksha Diagnostic Ltd's Q4 FY25…
- Narayana Hrudayalaya Ltd (Q4 FY25)
Capex is split between regular maintenance/replacement (~INR 300 crores) and new greenfield/brownfield capacity (~INR 450 crores) with some variability based…
Arthneeti Pro · Annual
Apollo Hospitals Enterprise Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Apollo Hospitals Enterprise Ltd Q4 FY25 results?
Apollo Hospitals expects continued healthy volume growth driven by increased patient footfall across specialties. The transcript indicates the following future growth expectations for Apollo Hospitals: - Revenue Growth: Expecting continued strong revenue growth driven by expansion in specialty and multi-specialty hospitals, and increased patient volumes.
What is Apollo Hospitals Enterprise Ltd share price analysis?
Apollo Hospitals Enterprise Ltd currently shows a neutral. The stock trades at a P/E of 59.4 with a market cap of ₹124,992 Cr. Investors should review the full earnings analysis for detailed insights.
Is Apollo Hospitals Enterprise Ltd planning capital expenditure?
The transcript does not explicitly mention current or future capex, capital investments, or strategic investments on page 2.
Keep Apollo Hospitals Enterprise Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.